Joint Filing Agreement
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G dated November 16, 2020 (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Ocuphire Pharma, Inc.. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: November 16, 2020 | Richmond Brothers, Inc. | ||
By: |
/s/ Xxxxx X. Xxxxxxxx | ||
Name: | Xxxxx X. Xxxxxxxx | ||
Title: | Chairman |
RBI Private Investment III, LLC | |||
By: | RBI PI Manager, LLC | ||
Manager | |||
By: |
/s/ Xxxxx X. Xxxxxxxx | ||
Name: | Xxxxx X. Xxxxxxxx | ||
Title: | Manager |
The RBI Opportunities Fund, LLC | |||
By: | RBI PI Manager, LLC | ||
Manager | |||
By: |
/s/ Xxxxx X. Xxxxxxxx | ||
Name: | Xxxxx X. Xxxxxxxx | ||
Title: | Manager |
The RBI Opportunities Fund II, LLC | |||
By: | RBI PI Manager, LLC | ||
Manager | |||
By: |
/s/ Xxxxx X. Xxxxxxxx | ||
Name: | Xxxxx X. Xxxxxxxx | ||
Title: | Manager |
By: | RBI PI Manager, LLC | ||
By: |
/s/ Xxxxx X. Xxxxxxxx | ||
Name: | Xxxxx X. Xxxxxxxx | ||
Title: | Manager |
/s/ Xxxxx X. Xxxxxxxx | |
Xxxxx X. Xxxxxxxx |
/s/ Xxxxxxx X. Xxxxxxx | |
Xxxxxxx X. Xxxxxxx |